share_log

Bringspring Science and Technology Co., Ltd.'s (SZSE:300290) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Bringspring Science and Technology Co., Ltd.'s (SZSE:300290) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

榮科科技有限公司(深圳證券交易所:300290)的財務數據過於模糊,無法與目前的股價走勢相關聯:這隻股票未來會如何?
Simply Wall St ·  12/09 12:17

Bringspring Science and Technology (SZSE:300290) has had a great run on the share market with its stock up by a significant 149% over the last three months. However, we wonder if the company's inconsistent financials would have any adverse impact on the current share price momentum. Specifically, we decided to study Bringspring Science and Technology's ROE in this article.

榮科科技(SZSE:300290)在股票市場上表現出色,過去三個月股票上漲了顯著的149%。然而,我們想知道公司不一致的財務數據會否對當前股價走勢產生不利影響。具體來說,我們決定在本文中研究榮科科技的roe。

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

roe或股東權益回報率是評估公司如何有效地從股東那裏獲得回報的有用工具。簡而言之,它用於評估公司相對於其權益資本的盈利能力。

How Is ROE Calculated?

淨資產收益率怎麼計算?

ROE can be calculated by using the formula:

roe可以通過以下公式計算:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

淨資產收益率 = 淨利潤(來自持續經營) ÷ 股東權益

So, based on the above formula, the ROE for Bringspring Science and Technology is:

所以,基於上述公式,榮科科技的roe爲:

2.6% = CN¥23m ÷ CN¥893m (Based on the trailing twelve months to September 2024).

2.6% = CN¥2300萬 ÷ CN¥89300萬(基於截至2024年9月的過去12個月)。

The 'return' is the amount earned after tax over the last twelve months. That means that for every CN¥1 worth of shareholders' equity, the company generated CN¥0.03 in profit.

「回報率」是指上一年度稅後收益,這意味着對於每1元股東權益,公司創造了0.03元的利潤。

What Has ROE Got To Do With Earnings Growth?

roe與盈利增長有何關係?

So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.

So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.

Bringspring Science and Technology's Earnings Growth And 2.6% ROE

榮科科技的盈利增長與2.6%的roe

It is hard to argue that Bringspring Science and Technology's ROE is much good in and of itself. Even when compared to the industry average of 4.6%, the ROE figure is pretty disappointing. For this reason, Bringspring Science and Technology's five year net income decline of 24% is not surprising given its lower ROE. We believe that there also might be other aspects that are negatively influencing the company's earnings prospects. Such as - low earnings retention or poor allocation of capital.

很難說榮科科技的roe本身就很好。即便與行業平均水平4.6%相比,roe數字也相當令人失望。因此,榮科科技過去五年淨利潤下降24%並不是意外,因爲其roe較低。我們認爲,可能還有其他因素在負面影響公司的盈利前景,比如低盈利留存或資本配置不當。

However, when we compared Bringspring Science and Technology's growth with the industry we found that while the company's earnings have been shrinking, the industry has seen an earnings growth of 2.5% in the same period. This is quite worrisome.

然而,當我們將榮科科技的增長與行業進行比較時,我們發現,儘管公司的盈利一直在縮水,但在同一時期,行業的盈利增長達到了2.5%。這相當令人擔憂。

big
SZSE:300290 Past Earnings Growth December 9th 2024
SZSE:300290 過去的盈利增長 2024年12月9日

Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. Is Bringspring Science and Technology fairly valued compared to other companies? These 3 valuation measures might help you decide.

盈利增長是股票估值的一個重要因素。投資者應該嘗試確定預期的盈利增長或下滑,無論是哪種情況,是否已經反映在價格中。這樣做將有助於他們判斷股票的未來看起來是有前景還是不妙。 榮科科技與其他公司相比是否被合理估值?這三項估值指標可能會幫助你做出決定。

Is Bringspring Science and Technology Using Its Retained Earnings Effectively?

榮科科技是否有效利用其留存收益?

While the company did payout a portion of its dividend in the past, it currently doesn't pay a regular dividend. This implies that potentially all of its profits are being reinvested in the business.

雖然該公司過去曾分紅一部分,但目前不支付常規股息。這意味着其所有的利潤都被重新投資於業務中。

Conclusion

結論

Overall, we have mixed feelings about Bringspring Science and Technology. While the company does have a high rate of reinvestment, the low ROE means that all that reinvestment is not reaping any benefit to its investors, and moreover, its having a negative impact on the earnings growth. Wrapping up, we would proceed with caution with this company and one way of doing that would be to look at the risk profile of the business. To know the 2 risks we have identified for Bringspring Science and Technology visit our risks dashboard for free.

總體而言,我們對榮科科技的看法比較複雜。雖然該公司的再投資率很高,但低roe意味着所有這些再投資對投資者沒有任何好處,而且對盈利增長產生負面影響。總結來說,我們對這家公司持謹慎態度,其中一種方式是查看其業務的風險概況。要了解我們爲榮科科技識別的兩個風險,請免費訪問我們的風險特斯拉-儀表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論